Data supporting this article. by Karel Joineau (21799908)

Subjects:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

Subjects:

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects:

Change of functional connectivity in the SMN after intervention. by Karel Joineau (21799908)

Subjects:

Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

Subjects:

Design of the protocol. by Karel Joineau (21799908)

Subjects:

Schema of the reflexology circuit and the stimulated reflex zones. a. by Karel Joineau (21799908)

Subjects:

Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

Subjects:

(A-B): Mean intraocular pressure (IOP) (A) and mean number of glaucoma medications (B) with standard deviations are shown for XEN (grey) and PRESERFLO (black) groups at baseline (p... by Cemre Altas (22537656)

Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

Subjects:

Regulation of IL8 cytokine in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

Subjects:

Regulation of NF-κB target genes. by Huan W. Yang (19746645)

Subjects:

Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

Subjects:

Growth of <i>L</i>. <i>intracellularis</i> strains Dkp23 and Vaccine in PK-15 cell lines. by Huan W. Yang (19746645)

Subjects:

Regulation of NF-κB nuclear translocation in the nucleus of Dkp23- or Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

Subjects:

Logistics regression analysis for the associations between decreased kidney function (eGFR < 90 mL/min/1.73 m²) and sex-specific z-scores of anthropometric indices, weig... by Xinyun Chen (6655703)

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Top view of the experimental setup. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”